The Past, Present and Future of Mobile Visits in Decentralized Clinical Trials:

Industry thought leaders imagine how mobile visits should evolve to meet the challenges of tomorrow.



  • 10:00 am Eastern time
  • Free

Why attend?


Select a speaker to learn more

Ellen Weiss
VP, In-Home Solutions, DCT, PCM Trials

Ellen Weiss connects CROs and sponsors with right-sized hybrid and remote solutions. She has spoken on the logistical support necessary for IMP delivery and dosing, sample collection, and the services provided by clinical trial research nurses that enable alternate-site visits to be carried out with the same data quality and subject safety as on-site visits. Ellen is a member of the Healthcare Businesswomen’s Association and a volunteer for the American Society of Clinical Oncology.

Next speaker
Next speaker
Deb Guattery
Standards and Process Lead, Decentralized Clinical Trials at Pfizer

Deb Guattery most recently worked at Pfizer as the Process Lead for Home Health and Decentralized Clinical Trials. In that role, she built the processes and expanded the services of home nursing visits and other decentralized trial elements to be written into clinical trial protocols. Deb also advised in the writing of WCG Avoca Key Performance Indicators for the use of home health visits in a clinical trial and is an active participant in collaborative groups within the Decentralized Trials and Research Alliance (DTRA).

Deb continues to seek the advance of decentralized elements like the use of home health visits with the ultimate goal of driving better recruitment and retention of more diverse patients in clinical trials.

Next speaker